1. Home
  2. WAFDP vs CMMB Comparison

WAFDP vs CMMB Comparison

Compare WAFDP & CMMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WAFDP
  • CMMB
  • Stock Information
  • Founded
  • WAFDP N/A
  • CMMB 2004
  • Country
  • WAFDP United States
  • CMMB Israel
  • Employees
  • WAFDP 2208
  • CMMB N/A
  • Industry
  • WAFDP Major Banks
  • CMMB Biotechnology: Pharmaceutical Preparations
  • Sector
  • WAFDP Finance
  • CMMB Health Care
  • Exchange
  • WAFDP Nasdaq
  • CMMB Nasdaq
  • Market Cap
  • WAFDP N/A
  • CMMB 37.3M
  • IPO Year
  • WAFDP N/A
  • CMMB N/A
  • Fundamental
  • Price
  • WAFDP $16.77
  • CMMB $1.96
  • Analyst Decision
  • WAFDP
  • CMMB Strong Buy
  • Analyst Count
  • WAFDP 0
  • CMMB 2
  • Target Price
  • WAFDP N/A
  • CMMB $7.50
  • AVG Volume (30 Days)
  • WAFDP N/A
  • CMMB 77.2K
  • Earning Date
  • WAFDP N/A
  • CMMB 03-06-2025
  • Dividend Yield
  • WAFDP N/A
  • CMMB N/A
  • EPS Growth
  • WAFDP N/A
  • CMMB N/A
  • EPS
  • WAFDP N/A
  • CMMB N/A
  • Revenue
  • WAFDP N/A
  • CMMB N/A
  • Revenue This Year
  • WAFDP N/A
  • CMMB N/A
  • Revenue Next Year
  • WAFDP N/A
  • CMMB N/A
  • P/E Ratio
  • WAFDP N/A
  • CMMB N/A
  • Revenue Growth
  • WAFDP N/A
  • CMMB N/A
  • 52 Week Low
  • WAFDP N/A
  • CMMB $0.55
  • 52 Week High
  • WAFDP N/A
  • CMMB $2.55
  • Technical
  • Relative Strength Index (RSI)
  • WAFDP 46.30
  • CMMB 46.64
  • Support Level
  • WAFDP $16.31
  • CMMB $1.86
  • Resistance Level
  • WAFDP $16.80
  • CMMB $2.06
  • Average True Range (ATR)
  • WAFDP 0.20
  • CMMB 0.14
  • MACD
  • WAFDP 0.03
  • CMMB -0.02
  • Stochastic Oscillator
  • WAFDP 66.67
  • CMMB 30.30

About WAFDP WaFd Inc. Depositary Shares

WaFd Inc is engaged in providing lending, depository, insurance, and other banking services to consumers, mid-sized to large businesses, and owners and developers of commercial real estate. Through the WaFd Bank, it is involved in accepting deposits from the general public and investing these funds in loans of various types, including first-lien mortgages on single-family dwellings, construction loans, land acquisition and development loans among others. The Bank also invests in certain United States government and agency obligations along with other investments and also performs insurance brokerage activities. Geographically, it operates in Washington, Oregon, Idaho, Arizona, Utah, Nevada, New Mexico, California and Texas.

About CMMB Chemomab Therapeutics Ltd.

Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life threatening fibrotic and inflammatory diseases. It is advancing three Phase 2 clinical trials in parallel for CM-101 treating rare fibrotic conditions.

Share on Social Networks: